Bristol-Myers Squibb Company
NYSE: BMY
$58.41
-$0.61 (-1.0%)
Closing Price on November 13, 2024
BMY Articles
24/7 Insights Dividend stocks offer investors the opportunity to increase investment total return. Companies that pay dependable dividends help generate passive income streams. Check out this free...
Published:
24/7 Insights Wounded blue chip stocks can offer huge total return potential. Stocks that pay big dividends can help provide long-term passive income streams. Access two legendary, high-yield...
Published:
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
Published:
24/7 Insights Quality dividend stocks can generate solid total returns and yield passive income. Stocks that pay dependable dividends should be in demand when interest rates drop. Access 2 legendary,...
Published:
The artificial intelligence rally over the past year and a half, led by the so-called Magnificent 7 stocks, has been remarkable if you owned those stocks. However, most of the S&P 500 is treading...
Published:
24/7 Insights The stock market is overbought and may be ready for a correction. Stifel’s Barry Bannister has called massive market moves in the past. Access 2 legendary, high-yield dividend stocks...
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Investors love dividend stocks because they provide dependable income and a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions...
Published:
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and...
Published:
With the first quarter half over and the major indices higher for 2024, many investors think a significant correction could be coming. After a tremendous 2023 and the solid start to this year, the...
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third quarter running. Many top...
Published:
2022 was a dreadful year for investors, with the S&P 500 down almost 20% and the Nasdaq lower by a stunning 33%. What a difference a year can make. In 2023, the S&P 500 was up 24.2 %, with...
Published:
Another acquisition for Bristol Myers, another acquisition offer from Nano Dimension, and Apple's Watch woes.
Published: